Literature DB >> 8805741

Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery disease.

V Di Bello1, C R Bellina, E Gori, N Molea, L Talarico, G Boni, E Magagnini, F Matteucci, D Giorgi, E Lazzeri, A Bertini, M F Romano, R Bianchi, C Giusti.   

Abstract

BACKGROUND: The incremental diagnostic value of dobutamine stress echocardiography (DSE) and 99mTc-labeled sestamibi single-photon emission computed tomography for the evaluation of the presence and extent of coronary artery disease (CAD) was assessed with ordered logistic regression and receiver-operating characteristic curves. METHODS AND
RESULTS: Forty-five consecutive patients (33 men and 12 women; 53 +/- 6.8 years) underwent exercise electrocardiography and simultaneous DSE and sestamibi single-photon emission computed tomographic imaging. Coronary angiography was performed in all patients (significant coronary stenosis > 50%). On the basis of the results of exercise electrocardiography, the pretest probability for CAD (Diamond's algorithm) was low (45.6% +/- 12.7%). According to ordered logistic regression analysis, some models were estimated that performed a diagnostic accuracy level for CAD. In particular, we evaluated a clinical model (model 1) determined by the following parameters: sex, age, presence of chest pain, and positivity of electrocardiogram during dobutamine stress test. This model was 64.3% +/- 10.7% accurate for the prediction of CAD. The addition to model 1 of DSE parameters (wall motion stress and rest score index and relative difference) (model 2) yielded a diagnostic accuracy of 81.4% +/- 4.3% (p < 0.045), whereas the addition to model 1 of single-photon emission computed tomographic parameters (the difference between perfusional stress and rest score index) (model 3) improved diagnostic accuracy to 92.3% +/- 5.5% (p < 0.003), a level that appeared significantly higher than that of model 2 (p < 0.016).
CONCLUSION: Both noninvasive methods for the detection of CAD showed a good diagnostic accuracy, especially when test-derived parameters were combined with clinical data. Nevertheless, the single-photon emission computed tomographic model showed a higher sensitivity compared with the DSE model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8805741     DOI: 10.1016/s1071-3581(96)90035-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  24 in total

Review 1.  Technetium 99m sestamibi in the assessment of chronic coronary artery disease.

Authors:  D S Berman; H Kiat; K Van Train; E Garcia; J Friedman; J Maddahi
Journal:  Semin Nucl Med       Date:  1991-07       Impact factor: 4.446

Review 2.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

3.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease.

Authors:  G A Diamond; J S Forrester
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

4.  Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography.

Authors:  D S Segar; S E Brown; S G Sawada; T Ryan; H Feigenbaum
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

5.  Dobutamine thallium myocardial perfusion tomography.

Authors:  D J Pennell; S R Underwood; R H Swanton; J M Walker; P J Ell
Journal:  J Am Coll Cardiol       Date:  1991-11-15       Impact factor: 24.094

6.  Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease.

Authors:  J R Mason; R T Palac; M L Freeman; S Virupannavar; H S Loeb; E Kaplan; R M Gunnar
Journal:  Am Heart J       Date:  1984-03       Impact factor: 4.749

7.  Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.

Authors:  H Mertes; S G Sawada; T Ryan; D S Segar; R Kovacs; J Foltz; H Feigenbaum
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

8.  Incremental prognostic accuracy of clinical, radionuclide and hemodynamic data in acute myocardial infarction.

Authors:  B P Griffin; P K Shah; G A Diamond; D S Berman; J G Ferguson
Journal:  Am J Cardiol       Date:  1991-09-15       Impact factor: 2.778

9.  A comparison of multivariable mathematical methods for predicting survival--III. Accuracy of predictions in generating and challenge sets.

Authors:  C K Wells; A R Feinstein; S D Walter
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

10.  Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography.

Authors:  T Marwick; B Willemart; A M D'Hondt; T Baudhuin; W Wijns; J M Detry; J Melin
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

View more
  6 in total

Review 1.  Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging.

Authors:  C Y Loong; C Anagnostopoulos
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

2.  Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease.

Authors:  G M Santoro; R Sciagrà; P Buonamici; N Consoli; V Mazzoni; F Zerauschek; G Bisi; P F Fazzini
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

3.  Simultaneous dobutamine stress echocardiography and dobutamine scintigraphy (99mTc-MIBI-SPET) for assessment of coronary artery disease.

Authors:  V De Bello; C R Bellina; N Molea; L Talarico; G Boni; E Magagnini; F Matteucci; D Giorgi; E Lazzeri; A Bertini; M F Romano; R Bianchi; C Giusti
Journal:  Int J Card Imaging       Date:  1996-09

4.  Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

5.  Comparison of dobutamine stress echocardiography, dobutamine SPECT, and adenosine SPECT myocardial perfusion imaging in patients with end-stage renal disease.

Authors:  Bradley A Bart; Ye-Ying Cen; Robert C Hendel; Ramond Lee; Thomas H Marwick; Emil D Missov; Fouad A Bachour; Charles A Herzog
Journal:  J Nucl Cardiol       Date:  2009-03-24       Impact factor: 5.952

Review 6.  Myocardial perfusion scintigraphy: the evidence.

Authors:  S R Underwood; C Anagnostopoulos; M Cerqueira; P J Ell; E J Flint; M Harbinson; A D Kelion; A Al-Mohammad; E M Prvulovich; L J Shaw; A C Tweddel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.